Trade ETF Series Solutions - Loncar China BioPharma ETF - CHNA CFD

Add to favourite

13.24

0.9%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.38

Long position overnight fee

-0.024151%

Short position overnight fee

0.001929%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	13.36
Open	13.14
1-Year Change	-4.58%
Day's Range	13.13 - 13.41

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Oct 20, 2023	13.24	0.08	0.61%	13.16	13.41	13.13
Oct 19, 2023	13.36	-0.17	-1.26%	13.53	13.58	13.33
Oct 18, 2023	13.65	-0.09	-0.66%	13.74	13.77	13.62
Oct 17, 2023	14.19	0.09	0.64%	14.10	14.26	14.09
Oct 16, 2023	14.36	0.20	1.41%	14.16	14.39	14.14
Oct 13, 2023	14.42	0.06	0.42%	14.36	14.47	14.35
Oct 12, 2023	14.21	-0.30	-2.07%	14.51	14.51	14.19
Oct 11, 2023	14.44	0.04	0.28%	14.40	14.51	14.36
Oct 10, 2023	14.28	0.40	2.88%	13.88	14.28	13.88
Oct 9, 2023	13.88	0.11	0.80%	13.77	13.88	13.75
Oct 6, 2023	13.99	0.28	2.04%	13.71	13.99	13.45
Oct 5, 2023	13.63	0.14	1.04%	13.49	13.63	13.49
Oct 4, 2023	13.58	-0.03	-0.22%	13.61	13.64	13.56
Oct 3, 2023	13.77	0.05	0.36%	13.72	13.80	13.72
Oct 2, 2023	14.10	-0.05	-0.35%	14.15	14.19	14.05
Sep 29, 2023	14.20	-0.10	-0.70%	14.30	14.31	14.16
Sep 28, 2023	14.50	0.10	0.69%	14.40	14.51	14.39
Sep 27, 2023	14.50	0.00	0.00%	14.50	14.53	14.41
Sep 26, 2023	14.21	0.00	0.00%	14.21	14.30	14.20
Sep 25, 2023	14.33	0.11	0.77%	14.22	14.36	14.22

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ETF Series Solutions - Loncar China BioPharma ETF Company profile

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index. The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.

News

Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target

Can Shiba Inu reinvent itself to become a worthy long-term investment?

08:36, 15 November 2024

Trump trades charge as Bitcoin hits $US80,000

Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.

10:48, 13 November 2024

Australian jobs data expected to point to solid labour market conditions

Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.

10:16, 13 November 2024

FOMC cuts interest rates as expected and sticks to its line on future policy

The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.

13:33, 8 November 2024

FOMC and BOE preview: further rate cuts expected

Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.

14:14, 5 November 2024

RBA meeting preview: No change to policy expected as inflation fight continues

The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.

13:35, 4 November 2024